期刊文献+

睡眠障碍评定量表的信度和效度分析 被引量:85

The Reliability and Validity of Sleep Dysfunction Rating Scale in Patients with Insomnia
下载PDF
导出
摘要 目的对睡眠障碍评定量表(SleepDysfunctionRatingScale,SDRS)进行信效度检验。方法选择符合CCMD-3的失眠症患者215例进行两次SDRS及临床总体印象量表(clinicalglobalimpressionscale-severi-ty,CGI-S)测试,两次间隔时间为3-7天。结果SDRS重测信度系数为0.89(P〈0.001);各条目的Cronbachα系数较高(0.85-0.88)。SDRS与CGI-S的相关系数为0.70(P〈0.001)。因子分析显示除条目8和9具有相近的公共因子负荷之外,其他条目分别单独负荷不同的公共因子。因子载荷范围在0.73至0.95之间。结论SDRS具有较好的信度和效度。 Objective: Psychometric evaluation of Sleep Dysfunction Rating Scale ( SDRS ) for insomnia. Methotis :The study sample consisted of 215 patients with insomnia (CCMD-3 ). The length of the test-retest interval was either 3 to 7 days. Results. In insomnic patients, the overall SDRS global score correlation coefficient for test-retest reliability was 0. 89 ( P 〈 0. 001 ). The items of SDRS homogeneity were high with Cronbach's alpha of 0. 85 - 0. 88. Valid- ity analyses showed high correlations between SDRS and CGI-S ( clinical global impression scale-severity ) data. The factor analysis showed that the factor loading and structure, which matched the structure of the scale approximately. The range of factor loading was between 0. 73 to 0. 95. Conclusion :The SDRS has a high reliability and a good validity in patients with insomnia.
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2007年第1期40-41,51,共3页 Chinese Mental Health Journal
关键词 心理测量学研究 睡眠障碍评定量表(SDRS) 信度 效度 因子分析 失眠症 psychometric study sleep dysfunction rating scale ( SDRS ) reliability validity factor analysis
  • 相关文献

参考文献12

  • 1Buysse DJ,Reynolds CF,Monk TH,et al.The Pittsburgh Sleep Quality Index:a new instrument for psychiatric practice and research.Psychiatry Res,1989,28:193-213.
  • 2Roth T,Drake C.Evolution of insomnia:current status and future direction.Sleep Med,2004,5(Suppl 1):23-30.
  • 3Violanir C,Devoto A,Lucidi F,et al.Validity of a Short Insomnia Questionnaire:the SDQ.Brain Res Bull,2004,63:415-421.
  • 4Douglass A,Borenstain R,Nino-Murcia G,et al.The sleep disorders questionnaire I.Creation and multivariate structure of SDQ.Sleep,1994,17:160-167.
  • 5Johns MW.A new method for measuring daytime sleepiness.Sleep,1991,14:540-545.
  • 6陈彦方.主编.CCMD-3中国精神障碍分类与诊断标准.第3版.济南:山东科学技术出版社,2001,118-119.
  • 7Soldatos CR,Dikeos DG,Paparrigopoulos TG:The diagnostic validity of the Athens Insomnia Scale.J Psychosomat Res,2003,55:263-267.
  • 8Soldatos CR,Dikeos DG,Paparrigopoulos TG.Athens Insomnia Scale:validation of an instrumentbased on ICD-10 criteria.J Psychosomat Res,2000,48:555-560.
  • 9Soldatos CR.The assessment of insomnia:rationale for a new scale based on ICD-10 principles.In:Szelenberger W,Kukwa A,editors.Sleep:Physiology and Pathology.Warszawa:Elma Books,1995.
  • 10赵靖平,陈晋东,陈远光,张鸿燕,舒良,马崔,李婷,孙学礼,李静,顾牛范,李华芳.扎莱普隆治疗失眠症的多中心随机双盲对照临床试验[J].中国临床药理学杂志,2002,18(2):87-89. 被引量:38

二级参考文献11

  • 1Cluydts R, Peeters K, de Bouyalsky I, Lavoisy J.Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double - blind, randomized pilot study.J Int Med Res 1998; 26: 13-24.
  • 2Parrino L, Boselli M, Spaggiari MC, Smerieri A, Terzano MG.Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattem. Clin Neuropharmacol 1997 ;20: 253-263.
  • 3Dockhom R J, Dockhom DW. Zolpidem in the treatment of shortterm insomnia : arandomized, double - blind, placebo - controlled clinical trial. Clin Neuropharmacol 1996 ; 19:333 -340.
  • 4Ware JC, Walsh JK, Scharf MB, Roehrs T, Roth T, Vogel GW. Minimal rebound insomnia after treatment with 10mg zolpidem.Clin Neuropharmacol 1997; 20: 116- 125.
  • 5Monti JM, Monti D, Estevez F, Giusti M. Sleep in patients with chronic primary insomnia during long- term zolpidem administration and after its withdrawal. Int Clin Psychopharmacol 1996; 11:255 - 263.
  • 6Roth T, Roehrs T, Vogel G.Zolpidem in the treatment of transient insomnia: a double- blind, randomized comparison with placebo.Sleep1995; 18 (4): 246-251.
  • 7Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL. Zolpidem and rebound insomnia- a double - blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry 1994; 27: 166- 175.
  • 8Sanger DJ, Morel E, Perrault G. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem[ J]. Eur J Pharmacol,1996,313:35-42.
  • 9Weitzel KW, Wickman JM,Augustin SG,et al. Zaleplon: a pyrazolopymidine sedative-hypnotic agent for the treatment of insomnia [ J ]. Clin Ther, 2000,22:1254-1267.
  • 10Drghramji PP. Treatment of insomnia with zaleplon, a novel sleep medication[ J]. Int J Clin Pract,2001,55: 329-334.

共引文献38

同被引文献836

引证文献85

二级引证文献1752

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部